Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah’s Witnesses-Reference-Cited by-同舟云学术

Bloodless chimeric antigen receptor (CAR) T-cell therapy in Jehovah’s Witnesses

Published:2021-02-03 Issue:6 Volume:62 Page:1497-1501
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Riedell Peter A.¹²^ORCID,Wu Meng³,Collins Jennifer M.⁴,Gideon Jacklyn M.¹²,Jakubowiak Andrzej J.¹²,Kline Justin P.¹²,Kosuri Satyajit¹²,Liu Hongtao¹²,Smith Sonali M.¹,Bishop Michael R.¹²^ORCID

Affiliation:

1. Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL, USA

2. David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL, USA

3. Department of Medicine, University of Chicago, Chicago, IL, USA

4. Department of Pharmacy, University of Chicago, Chicago, IL, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1876868

Reference17 articles.

1. Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

2. Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

3. Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

4. Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study

5. Axicabtagene Ciloleucel [package insert]. Santa Monica, CA: Kite Pharma; 2017.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extranodal diffuse large B-cell lymphoma presenting with extensive organ involvement;BMJ Case Reports;2024-06

2. Axicabtagene-ciloleucel/cyclophosphamide/tisagenlecleucel;Reactions Weekly;2021-07

3. When blood transfusion is not an option owing to religious beliefs;Annals of Blood;2021-01